Previous Close | 39.21 |
Open | 39.25 |
Bid | 29.50 x 1100 |
Ask | 65.26 x 800 |
Day's Range | 38.81 - 41.44 |
52 Week Range | 26.70 - 81.99 |
Volume | |
Avg. Volume | 27,729 |
Market Cap | 280.781M |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | 26.15 |
EPS (TTM) | 1.57 |
Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 65.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for SMLR
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that a study was published in the peer-reviewed AJPM Focus with data collected using the company's QuantaFlo® PAD test under real-world conditions, illustrating the benefits of PAD in-home screening. AJPM Focus is the official open access journal jointly launched this year by both The American College of Preventive Medi
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced an up to $5.0 million investment in privately-held Monarch Medical Technologies, LLC (Monarch) through the purchase of a senior secured convertible promissory note. Repayment of the note is secured by a first priority interest in all of Monarch's assets.
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and nine months ended September 30, 2022.